Loading
Invented the Cytosponge, a swallowable sponge-on-a-string that finds Barrett's oesophagus without endoscopy.
Rebecca Fitzgerald developed the Cytosponge-TFF3 test and led the BEST3 trial in 13,000 patients showing it detects ten times more Barrett's oesophagus than usual care in people with reflux, which is now being rolled out in NHS pilots to catch oesophageal cancer early. She also led the OCCAMS genomic study of oesophageal adenocarcinoma and directs Cambridge's Early Cancer Institute.
Shares Cancer Research UK, Oesophageal cancer.
Shares Cancer Research UK, Oesophageal cancer.
Shares the tags early-detection, uk.
Shares the tags early-detection, uk.
Shares Cancer Research UK Cambridge Centre / CRUK Cambridge Institute and the tag uk.
Shares Multi-cancer early detection (MCED) and the tag early-detection.
Shares Oesophageal cancer and the tag esophageal.
Shares Multi-cancer early detection (MCED) and the tag early-detection.